Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Naomi Fried
AddedMar 31, 2024
UpdatedMay 31, 2026
Naomi Fried

Naomi Fried

Board Member, nQ Medical

LinkedIn

Naomi Fried's Career

nQ Medical
nQ Medical

Cambridge, MA, US

Board Member· Board
Wavely Diagnostics
Wavely Diagnostics

Seattle, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Naomi Fried's Career

nQ Medical
nQ Medical
Seed$4.5M252016Cambridge, MA, US
Board Member· Board

Leadership at nQ Medical

Mark PascarellaMark PascarellaBoard Member
R. A. BavassoR. A. BavassoCo-Founder
David Lee Scher, MDDavid Lee Scher, MDBoard Member

Similar to nQ Medical

Neuro42Neuro42Oakland, CA, USMedical Devicesest. 2020Neuro42Oakland, CA, US · est. 2020

neuro42: Innovating advanced MRI tech for diagnosing and treating neurological conditions.

Series B · $12.8M26
Neuroview TechnologyNeuroview TechnologyEnglewood, NJ, USMedical Devicesest. 2016Neuroview TechnologyEnglewood, NJ, US · est. 2016

Neuroview Technology: A data-driven platform specializing in medical devices.

Angel · $554.5k10
NeurotrackNeurotrackRedwood City, CA, USAssessments, Healthcareest. 2012NeurotrackRedwood City, CA, US · est. 2012

US-based Neurotrack offers healthcare services, specializing in identifying and treating Alzheimer's disease.

Series A · $60.4M37
PainQxPainQxNew York City, NY, USMedical Devicesest. 2015PainQxNew York City, NY, US · est. 2015

PainQx: An AI-driven medical device firm innovating objective pain measurement and monitoring.

Seed · $3.8M8
Wavely Diagnostics
Wavely Diagnostics
Seed$5.6M112018Seattle, WA, US
Board Member· Board

Leadership at Wavely Diagnostics

Randall A. BlyRandall A. BlyCo-Founder
Shyam GollakotaShyam GollakotaCo-Founder
Justin ChanJustin ChanCo-Founder
Arna Ionescu StollArna Ionescu StollCEO
Sharat RajuSharat RajuCo-Founder
Sasha SchrodeSasha SchrodeBoard Member

Similar to Wavely Diagnostics

Accessible DiagnosticsAccessible DiagnosticsGreenville, SC, USMedical Testsest. 2014Accessible DiagnosticsGreenville, SC, US · est. 2014

Accessible Diagnostics: Providing at-home, smartphone-based medical tests for healthier families.

Seed · $219k3
Scanwell HealthScanwell HealthDiagnostics, Healthcareest. 2018Scanwell Healthest. 2018

Scanwell Health: Smartphone diagnostics for at-home testing

Acquired · $120k
Steth IOSteth IOBothell, WA, USMedical Devicesest. 2015Steth IOBothell, WA, US · est. 2015

Steth IO develops smartphone stethoscopes for real-time heart and lung sound visualization.

Seed · $1.9M5
TytoCareTytoCareNew York City, NY, USMedical Devicesest. 2011TytoCareNew York City, NY, US · est. 2011

An innovative remote platform enabling accurate physical examinations and diagnosis anywhere, anytime.

Series D · $205.7M243

Naomi Fried's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Naomi Fried

John FunkhouserJohn FunkhouserCEO · PharmaneticsRonald GoldRonald GoldBoard Member · NJ BioGrigory PotapovGrigory PotapovCEO · PharmstandardAnil GulatiAnil GulatiFounder · EndogenxJonathan SacksJonathan SacksCEO · PharmAdva